LEADER 01155nam0 22003013i 450 
001 VAN0131049
005 20230411014508.145
017 70$2N$a978-3-319-43063-8
100   $a20201005d2017       |0itac50      ba
101   $aeng
102   $aCH
105   $a||||    |||||
200 1 $aImmunotherapy for Gastrointestinal Cancer$fDavid Kerr, Rebecca Johnson editors
205   $aCham : Springer, 2017
210   $avii$d252 p.$cill. ; 24 cm
215   
620   $aCH$dCham$3VANL001889
702  1$aJohnson$bRebecca$3VANV104816
702  1$aKerr$bDavid$3VANV088752
712   $aSpringer <editore>$3VANV108073$4650
801   $aIT$bSOL$c20240614$gRICA
856 4 $u https://link.springer.com/book/10.1007%2F978-3-319-43063-8$zE-book ? Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o Shibboleth
899   $aBIBLIOTECA CENTRO DI SERVIZIO SBA$2VAN15
912   $fN
912   $aVAN0131049
950   $aBIBLIOTECA CENTRO DI SERVIZIO SBA$d15CONS      SBA EBOOK 7123                      $e15EB 7123              20201006            
996   $aImmunotherapy for Gastrointestinal Cancer$91757960
997   $aUNICAMPANIA